Coinbase Expands Beyond Crypto: Stock Trading, Derivatives, and SEC-Registered AI Advisor

Coinbase has announced a significant expansion of its product suite, moving beyond its core cryptocurrency exchange business to offer stock trading, derivatives, and an artificial intelligence-powered investment advisory tool. The move signals the company’s ambition to become a one-stop financial platform for retail and advanced traders alike.

New Products Span Stocks, Derivatives, and AI

According to a report from CoinDesk, the exchange now allows users to trade options on both cryptocurrencies and U.S. equities. Through its Coinbase Advanced platform, users can transfer stock portfolios from other brokerages and trade a mix of crypto, U.S. stocks, ETFs, and stock indices. This integration directly competes with traditional brokerage platforms like Robinhood and Charles Schwab.

On the derivatives side, Coinbase is launching perpetual futures tied to thematic baskets, including AI-related companies, the defense industry, and Chinese stocks. It is also introducing pre-IPO perpetual futures for private companies, giving traders exposure to high-growth firms before they go public.

Coinbase Advisor: An SEC-Registered AI Tool

Perhaps the most notable announcement is the launch of Coinbase Advisor, which the company describes as one of the first AI-powered investment advisory tools registered with the U.S. Securities and Exchange Commission (SEC). The tool is designed to provide portfolio recommendations, tax-loss harvesting strategies, and market analysis. It will initially be available to Coinbase One subscribers in the United States.

Why This Matters for Traders

This expansion positions Coinbase as a direct competitor to established financial institutions and fintech platforms. For users, it means the ability to manage a broader range of assets within a single account, potentially simplifying portfolio management and reducing the need for multiple brokerage accounts. The integration of an SEC-registered AI advisor also adds a layer of regulatory credibility, which could attract more risk-averse investors.

Broader Implications for the Crypto and Finance Industry

Coinbase’s move reflects a broader trend of crypto-native companies expanding into traditional finance. By offering stocks and SEC-registered advisory services, the company is bridging the gap between decentralized and traditional markets. This could accelerate mainstream adoption of digital assets by providing a familiar, regulated entry point for new investors.

However, the expansion also raises questions about regulatory oversight, particularly regarding the integration of AI in financial advice and the cross-border trading of derivatives. The SEC’s registration of Coinbase Advisor suggests a willingness to work with innovative fintech products, but ongoing scrutiny is likely.

Conclusion

Coinbase’s latest product rollout marks a strategic pivot from a pure-play crypto exchange to a comprehensive financial services platform. By combining crypto, stocks, derivatives, and AI-driven advisory tools under one roof, the company is betting that integration and regulatory compliance will win over a broader user base. For investors, the key takeaway is the growing convergence of traditional and digital finance, with Coinbase positioning itself at the center of that shift.

FAQs

Q1: Can I now trade stocks on Coinbase?
Yes. Coinbase Advanced now supports trading of U.S. stocks, ETFs, and stock indices, in addition to cryptocurrencies. Users can also transfer stock portfolios from other brokerages.

Q2: What is Coinbase Advisor?
Coinbase Advisor is an AI-powered investment tool registered with the SEC. It offers portfolio recommendations, tax-loss harvesting, and market analysis, and is initially available to Coinbase One subscribers in the U.S.

Q3: Are the new derivatives products available to all users?
Coinbase is launching perpetual futures tied to thematic baskets (AI, defense, Chinese stocks) and pre-IPO perpetual futures. Availability may vary by jurisdiction and user eligibility based on regulatory requirements.